MiRNA and Target Oncogene Regulation in Triple Negative Breast Cancer: An Age, Ethnic and Environmental Related Neoplastic Event
Journal Title: Journal of Cancer and Tumor International - Year 2015, Vol 2, Issue 2
Abstract
Triple-negative breast cancer is a type of aggressive breast cancer without the immunohistochemical expression of estrogen receptors, progesterone receptors and human epidermal growth factor receptor-2; with poor prognosis, greater relapse risk and worse survival in general. Its proportion in all breast cancer cases ranges from 15 to 20%. Triple negative breast cancer is more prevalent among younger women, particularly African, African-American, Latino and obese women. This observed prevalence, is an age and ethnic related factor which fingers estrogenic agents as a common feature in TNBC occurrence. Inherited variation in the let-7 binding site on the KRAS oncogene has been revealed to confer increased susceptibility to triple negative breast cancer, especially in premenopausal, African-American and Hispanic women. About 15-40% of triple negative breast tumors have BRCA-related epigenetic down-regulation and increased expression of the inhibitors of BRCA1 function, which have be found to be related to indirect regulation of ID4 oncogene by miR-342. When compared with wholesome breast tissues, miR-21, miR-210 and miR-221 expression are observed to be elevated in the triple-negative breast cancer; whereas expression of miR-10b, miR-145, miR-205, miR-122a, miR-200a/miR-200b, miR-146b and miR-148a are decreased. Interestingly, eight miRNAs are differentially expressed in metastatic breast cancer tissues (miR-200b, miR- 148a, miR-424, miR-125a-5P, miR-627, miR-579, let-7g and miR-101) when compared with the non-metastatic type. The consequence of differential miRNA expression in triple negative breast is a function of target oncogene modulation which may be related to nutritional, environmental and socio-cultural factors. Insights into the risk factors, miRNA and their validated target may provide novel diagnostic tools and treatment options for triple negative breast cancer.
Authors and Affiliations
Jude Ogechukwu Okoye, Francis Obinna Okoye
Keywords
Related Articles
- EP ID EP242946
- DOI 10.9734/JCTI/2015/18131
- Views 134
- Downloads 0
Sarcomatoid Carcinoma (Carcinosarcoma) of the Prostate Gland: A Review of the Literature
Background: Adenocarcinomas of the prostate gland are commonly encountered globally but other uncommon variants of carcinoma of the prostate are sporadically encountered including primary sarcomatoid carcinoma of the pro...
No Evidence for Association of -2518 A/G Promoter Polymorphism of MCP-1 with Risk of Esophageal Cancer in Punjab, North-West India
Aim: To investigate the role of MCP-1 -2518 A/G polymorphism in the susceptibility to esophageal cancer in patients from Punjab, North-West India. Methods: In this case-control study, 159 sporadic esophageal cancer patie...
Long Time Survival in Small Cell Carcinoma of the Bladder: A Case Report
Small cell carcinoma of the bladder only accounts for 0,35 – 1% of all bladder cancers. It is a rare, but aggressive tumor. As for other types of bladder cancer, first symptoms are most often painless hematuria [1,2]. Th...
Outcome and Predictive Factors of Radiation Therapy for Medulloblastoma: Mansoura Experience
Background: Medulloblastomas are the most common infratentorial malignant brain tumors with an incidence rate of 0.5 in 100.000 typically arising in childhood at age 5-9 years. Aim of Work: Exploring the epidemiological...
Occurrence of Factors Influencing Recurrence and/or Metastasis in Dermatofibrosarcoma Protuberans
Introduction: Dermatofibrosarcoma protuberans (DFSP) is a slow growing tumour with limited metastatic potential. However it acquires aggressive attributes as it enlarges or if it recurs following excision. The fibrosarco...